Sugato De | VP, Regulatory Strategy, Head of MedTech
Allucent

Sugato De, VP, Regulatory Strategy, Head of MedTech, Allucent

As a previous Senior Policy Advisor at the FDA, as well as a seasoned leader within the CRO industry, Sugato has cultivated expertise in a plethora of regulatory pathways, including dossiers for combination products, expedited pathways, protocol development for medical devices, and more. During his 11-year tenure with the Center for Devices and Radiological Health (CDRH) at the US FDA, Sugato developed specialized expertise in drug-device combination products, digital health technologies, and critical care medicine.

Appearances:



Main Congress Day 2 - 23rd April @ 12:10

Novel Vaccine Delivery Technologies: Clinical and Regulatory Considerations

  • Novel technologies to facilitate vaccine delivery
  • An overview of FDA’s Platform Technology Designation Program
  • Bridging considerations for combination products
Session led by: allucent
last published: 22/Apr/25 22:05 GMT

back to speakers